Citadel Advisors »

Immunovant shares owned by Citadel Advisors

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $15M 524k 28.51
2024-06-30 $13M 477k 26.40
2024-03-31 $11M 333k 32.31
2023-12-31 $44M 1.0M 42.13
2023-09-30 $48M 1.2M 38.39
2023-06-30 $8.2M 430k 18.97
2023-03-31 $20M 1.3M 15.51
2022-12-31 $21M 1.2M 17.75
2022-06-30 $1.3M 339k 3.89
2022-03-31 $2.6M 467k 5.51
2021-12-31 $6.0M 703k 8.52
2021-09-30 $9.9M 1.1M 8.68
2021-06-30 $13M 1.2M 10.57
2021-03-31 $13M 780k 16.04
2020-12-31 $36M 769k 46.18
2020-09-30 $25M 701k 35.19
2020-06-30 $5.2M 214k 24.35
2020-03-31 $276k 18k 15.54